![](https://d3ilqtpdwi981i.cloudfront.net/qk6H7tecz3X-wHoi_Ugirx9ZDKA=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/cd/67/aa/cd67aa81-d484-45a2-85c8-a7986a28cc3c/thumbnail_6425d078-f0ca-4a41-ab6a-38b7a1b48a87.jpg)
Article
COVID-19 and myocarditis: a brief review
Frontiers in Bioscience
Document Type
Article
Publication Date
2-21-2022
Abstract
Cardiovascular complications (especially myocarditis) related to COVID-19 viral infection are not well understood, nor do they possess a well recognized diagnostic protocol as most of our information regarding this issue was derived from case reports. In this article we extract data from all published case reports in the second half of 2020 to summarize the theories of pathogenesis and explore the value of each diagnostic test including clinical, lab, ECG, ECHO, cardiac MRI and endomyocardial biopsy. These tests provide information that explain the mechanism of development of myocarditis that further paves the way for better management.
DOI Link
10.31083/j.fbl2702073
Publisher
IMR Press
Disciplines
Keywords
- COVID-19,
- Myocarditis,
- SARS-CoV-2
Scopus ID
85125562783
Creative Commons License
Creative Commons Attribution 4.0 International
Indexed in Scopus
Yes
Open Access
Yes
Open Access Type
Hybrid: This publication is openly available in a subscription-based journal/series
Citation Information
Fatma Taher, Athar Eysa, Dalia Fahmy, Ahmed Shalaby, et al.. "COVID-19 and myocarditis: a brief review" Frontiers in Bioscience Vol. 27 Iss. 2 (2022) ISSN: <a href="https://v2.sherpa.ac.uk/id/publication/issn/2768-6698" target="_blank">2768-6698</a> Available at: http://works.bepress.com/fatma-taher/34/